Skip to main content

Table 1 Characteristics of study patients according to CKD stage

From: Thyroid dysfunction and dyslipidemia in chronic kidney disease patients

Variables

All patients N = 360

Stage 3 N = 144

Stage 4 N = 156

Stage 5 N = 60

P value

Age (Years)

44.1 ± 16.4

41.9 ± 16.1

47.5 ± 15.6

40.3 ± 17.7

0.002

Sex

 Male

53.8 % (194)

18.8 % (68)

25.2 % (91)

9.7 % (35)

0.117

 Female

46.1 % (166)

21.1 % (76)

18.0 % (65)

6.9 % (25)

Diabetes mellitus

45.8 % (165)

18.3 % (66)

17.5 % (63)

10 % (36)

0.035

Hypertension

70.2 % (253)

25.5 % (92)

31.3 % (113)

13.3 % (48)

0.053

Cardiovascular disease

46.9 % (169)

11.9 % (43)

22.5 % (81)

12.5 % (45)

<0.001

Urea (mg/dL)

106.3 ± 60.1

71.3 ± 39.5

100.7 ± 37.7

204.7 ± 39.5

<0.001

Creatinine (mg/dL)

4.0 ± 3.4

1.8 ± 0.3

3.3 ± 0.5

10.9 ± 3.2

<0.001

eGFR (ml/min per 1.73 m2)

28.2 ± 15.3

44.0 ± 8.9

22.0 ± 4.0

6.4 ± 2.6

<0.001

Free T3 (pmol/L)

4.9 ± 1.1

5.0 ± 1.1

4.9 ± 1.1

4.7 ± 0.8

0.131

Free T4 (pmol/L)

11.6 ± 3.2

11.9 ± 3.2

11.5 ± 3.3

11.0 ± 2.6

0.175

TSH (mIU/L)

3.2 (1.8, 6.8)

2.5 (1.6, 4.3)

3.3 (1.7, 7.3)

5.4 (2.3, 8.8)

<0.001

Glucose (mg/dL)

117.4 ± 44.6

119.9 ± 45.6

116.7 ± 46.7

113.0 ± 36.1

0.596

Total cholesterol (mg/dL)

191.9 ± 31.7

194.2 ± 32.9

189.9 ± 31.3

191.6 ± 29.4

0.501

HDL cholesterol (mg/dL)

42.1 ± 5.9

42.0 ± 5.8

42.0 ± 6.0

42.7 ± 6.1

0.718

LDL cholesterol (mg/dL)

103.6 ± 28.1

106.1 ± 30.9

100.6 ± 25.6

105.0 ± 26.7

0.215

Triglyceride (mg/dL)

205.7 ± 73.9

205.9 ± 79.8

207.1 ± 70.4

201.6 ± 68.8

0.884

  1. The data is presented as mean ± SD (except for TSH level which showed non-normal distribution and is expressed as median) for continuous variables and as percentage (number) for categorical variables. P value was calculated at 95 % confidence interval among CKD stages 3–5 for different variables using one way ANOVA and Kruskal Wallis test for continuous variables, and chi square test for categorical variables